dc.creatorRai, Mahendra
dc.creatorIngle, Avinash P
dc.creatorGade, Aniket K
dc.creatorDuarte, Marta Cristina Teixeira
dc.creatorDuran, Nelson
dc.date2015-Oct
dc.date2016-05-23T19:40:48Z
dc.date2016-05-23T19:40:48Z
dc.date.accessioned2018-03-29T01:28:19Z
dc.date.available2018-03-29T01:28:19Z
dc.identifierIet Nanobiotechnology / Iet. v. 9, n. 5, p. 280-287, 2015-Oct.
dc.identifier1751-8741
dc.identifier10.1049/iet-nbt.2014.0068
dc.identifierhttp://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=7293533
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/235380
dc.identifier26435281
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1303623
dc.descriptionThe authors report extracellular mycosynthesis of silver nanoparticles (AgNPs) by Phoma capsulatum, Phoma putaminum and Phoma citri. The AgNPs thus synthesised were characterised by UV-visible spectrophotometer, Fourier transform infrared spectroscopy, Nanosight LM20 and transmission electron microscopy, which confirmed the synthesis of mostly spherical and polydisperse nanoparticles capped with proteins. The size of AgNPs was found in the range of 10-80 , 5-80 and 5-90 nm with an average size of 31.85, 25.43 and 23.29 nm by P. capsulatum, P. putaminum and P. citri, respectively. Further, potential antimicrobial activity was reported against Aspergillus niger, Candida albicans, Salmonella choleraesuis, Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli. The lowest minimal inhibitory concentration (MIC) (0.85 µg/ml) was reported for AgNPs synthesised from P. citri against S. choleraesuis. However, AgNPs synthesised from P. capsulatum showed the highest MIC (10.62 µg/ml) against S. choleraesuis, P. aeruginosa and E. coli (clinical isolate). The same MIC values (10.62 µg/ml) were also reported against P. aeruginosa and both clinical and standard isolates of E. coli for AgNPs synthesised from P. citri. It was also observed that all the silver nanoparticles showed remarkable antifungal and antibacterial activity against these tested pathogens as compared with the commercially available antifungal and antibacterial agents.
dc.description9
dc.description280-287
dc.languageeng
dc.relationIet Nanobiotechnology / Iet
dc.relationIET Nanobiotechnol
dc.rightsfechado
dc.sourcePubMed
dc.subjectAnti-infective Agents
dc.subjectAscomycota
dc.subjectBacteria
dc.subjectBiotechnology
dc.subjectFungi
dc.subjectMetal Nanoparticles
dc.subjectMicrobial Sensitivity Tests
dc.subjectParticle Size
dc.subjectSilver
dc.titleThree Phoma Spp. Synthesised Novel Silver Nanoparticles That Possess Excellent Antimicrobial Efficacy.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución